Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vivo tracking for cell therapies.

M Thompson1, D M Wall, R J Hicks

  • 1Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, 1 A'Beckett Street, East Melbourne, Australia 8006.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|January 13, 2006
PubMed
Summary

Tracking cellular therapies with nuclear medicine imaging is key for optimizing treatment. This approach visualizes cell migration, ensuring effective delivery and therapeutic response for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.

The British journal of dermatology·2020
Same author

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

The British journal of dermatology·2020
Same author

A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome.

The British journal of dermatology·2019
Same author

Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease.

The British journal of dermatology·2019
Same author

Rare T-Cell Subtypes.

Cancer treatment and research·2019
Same author

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

The British journal of dermatology·2018

Area of Science:

  • Nuclear medicine
  • Cellular therapy
  • Medical imaging

Background:

  • Cellular therapy success depends on agent migration, number, and response.
  • Optimizing therapy is complex due to numerous production, administration, and host variables.
  • Direct visualization of in vivo cell migration is crucial for assessing these variables.

Purpose of the Study:

  • To highlight the importance of imaging techniques for evaluating cellular therapy efficacy.
  • To emphasize the benefits of nuclear medicine, particularly PET imaging, for tracking cell migration.
  • To advocate for the early integration of cell tracking studies into clinical trials.

Main Methods:

  • Utilizing conventional radionuclide cell labeling for biodistribution.
  • Employing Positron Emission Tomography (PET) isotope labeling for enhanced sensitivity and resolution.

Related Experiment Videos

  • Conducting imaging studies to visualize and quantify in vivo cell migration patterns.

    • Main Results:

    • Imaging studies provide definitive evidence of successful targeting.
    • Quantification of cell migration to specific sites is achievable.
    • Tracking studies allow for patient-by-patient evaluation of therapeutic variables.

    Conclusions:

    • Direct visualization via nuclear medicine significantly aids in appraising factors affecting cellular therapy.
    • PET imaging offers superior sensitivity and resolution for cell tracking.
    • Integrating cell tracking into early clinical trials provides proof of mechanism and facilitates therapy optimization.